Small organic molecules that modulate gene transcription

Drug Discovery Today

Volumn 11, Issue 9-10, 2006, Pages 452-457

  Jung, Dongju ^a   Choi, Yongmun ^a   Uesugi, Motonari ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANOLOL; CCAAT ENHANCER BINDING PROTEIN BETA; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DEXAMETHASONE DERIVATIVE; DISTAMYCIN A; DNA; HEAT SHOCK PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMIDAZOLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; ISOXAZOLIDINE DERIVATIVE; KG 501; NAPHTHOL DERIVATIVE; NUTLIN; NUTLIN 1; NUTLIN 2; NUTLIN 3; PROTEIN MDM2; PROTEIN P53; RNA POLYMERASE II; STEROID HORMONE; SYNTHETIC PEPTIDE; SYNTHETIC TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; WRENCHNOLOL;

ALPHA HELIX; APOPTOSIS; BINDING SITE; BIOLOGICAL ACTIVITY; BREAST TUMOR; CANCER INHIBITION; CELL CULTURE; CELL CYCLE ARREST; CELL MEMBRANE; CHEMICAL ANALYSIS; DNA BINDING; DNA SEQUENCE; DNA STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; GENE; GENE SEQUENCE; HUMAN; LIGAND BINDING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; XENOGRAFT;

ADAMANTANE; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; HUMANS; INDOLES; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33646096458     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2006.03.011     Document Type: Review

References (34)

1. Dervan P.B. Molecular recognition of DNA by small molecules. Bioorg. Med. Chem. 9 (2001) 2215-2235
2. Gottesfeld J.M., et al. Regulation of gene expression by small molecules. Nature 387 (1997) 202-205
3. Dickinson L.A., et al. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12890-12895
4. Olenyuk B.Z., et al. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16768-16773
5. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
6. Feng W., et al. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science 280 (1998) 1747-1749
7. Triezenberg S.J. Structure and function of transcriptional activation domains. Curr. Opin. Genet. Dev. 5 (1995) 190-196
8. Tjian R., and Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell 77 (1994) 5-8
9. Uesugi M., et al. Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science 277 (1997) 1310-1313
10. Uesugi M., and Verdine G.L. The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14801-14806
11. Choi Y., et al. Divergent hTAFII31-binding motifs hidden in activation domains. J. Biol. Chem. 275 (2000) 15912-15916
12. Giniger E., and Ptashne M. Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit. Nature 330 (1987) 670-672
13. Kussie P.H., et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 (1996) 948-953
14. Radhakrishnan I., et al. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91 (1997) 741-752
15. Freedman S.J., et al. Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5367-5372
16. Dames S.A., et al. Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 5271-5276
17. Rose R.B., et al. Structural basis of dimerization, coactivator recognition and MODY3 mutations in HNF-1alpha. Nat. Struct. Biol. 7 (2000) 744-748
18. Slamon D.J., et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
19. Slamon D.J., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
20. Chang C.H., et al. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis. Oncogene 14 (1997) 1617-1622
21. Scott G.K., et al. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem. 269 (1994) 19848-19858
22. Asada S., et al. External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12747-12752
23. Naar A.M., et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398 (1999) 828-832
24. Rachez C., et al. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398 (1999) 824-828
25. Boyer T.G., et al. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 399 (1999) 276-279
26. Ryu S., et al. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 397 (1999) 446-450
27. Asada S., et al. A gene-expression inhibitor that targets an alpha-helix-mediated protein interaction. J. Am. Chem. Soc. 125 (2003) 4992-4993
28. Shimogawa H., et al. A wrench-shaped synthetic molecule that modulates a transcription factor-coactivator interaction. J. Am. Chem. Soc. 126 (2004) 3461-3471
29. Best J.L., et al. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17622-17627
30. Hollstein M., et al. p53 mutations in human cancers. Science 253 (1991) 49-53
31. Vassilev L.T., et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 (2004) 844-848
32. Kwon Y., et al. Small molecule transcription factor mimic. J. Am. Chem. Soc. 126 (2004) 15940-15941
33. Minter A.R., et al. A small molecule transcriptional activation domain. J. Am. Chem. Soc. 126 (2004) 10504-10505
34. Liu B., et al. A potent transactivation domain mimic with activity in living cells. J. Am. Chem. Soc. 127 (2005) 8254-8255